<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02852993</url>
  </required_header>
  <id_info>
    <org_study_id>P/2013/176</org_study_id>
    <nct_id>NCT02852993</nct_id>
  </id_info>
  <brief_title>Survival After Blood Transfusion in the French Administrative Regions of Burgundy and Franche-Comté</brief_title>
  <acronym>STeF-BFC</acronym>
  <official_title>Survival After Blood Transfusion in the French Administrative Regions of Burgundy and Franche-Comté</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre Hospitalier Universitaire de Dijon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Etablissement Français du Sang</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Red blood cell transfusion (RBC) is the main symptomatic treatment for severe anemia. RBC
      transfusion has proven its efficacy regarding mortality and morbidity, but it is not without
      side effects. The infectious side effects of transfusion are largely considered under
      control, non-infectious side effects are taking center stage. Seeking explanations for the
      beneficial and deleterious effects of RBC transfusions is necessary to ensure the safe and
      optimal use of this precious resource.

      The investigators aim to study the impact of donor and RBC characteristics on patient
      survival.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">16099</enrollment>
  <condition>Erythrocyte Transfusion for All Conditions</condition>
  <arm_group>
    <arm_group_label>Transfused patients</arm_group_label>
    <description>A cohort of patients receiving erythrocyte transfusion for the first time at the CHU Besançon or CHU Dijon during the study period.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The eligible patients consisted of all adult patients transfused for the first time
        (defined as patients with no known history of RBC unit use in the transfusion register), at
        the university hospitals of Besançon or Dijon, between January 2007 and December 2011.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 18 and over

          -  Erythrocyte Transfusion between 2007 and 2011

          -  Performed at the University Hospital of Besançon or Dijon

        Exclusion Criteria:

          -  Transfusion of any blood product prior to January 1st, 2007
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maxime Desmarets, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre d'Investigation Clinique; CHU Besançon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre d'Investigation Clinique, CHU de Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Département d'information Médicale, CHU Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Desmarets M, Bardiaux L, Benzenine E, Dussaucy A, Binda D, Tiberghien P, Quantin C, Monnet E. Effect of storage time and donor sex of transfused red blood cells on 1-year survival in patients undergoing cardiac surgery: an observational study. Transfusion. 2016 May;56(5):1213-22. doi: 10.1111/trf.13537. Epub 2016 Mar 2.</citation>
    <PMID>26935140</PMID>
  </results_reference>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 29, 2016</study_first_submitted>
  <study_first_submitted_qc>August 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 2, 2016</study_first_posted>
  <last_update_submitted>August 1, 2016</last_update_submitted>
  <last_update_submitted_qc>August 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 2, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Erythrocyte Transfusion</keyword>
  <keyword>Survival</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

